Literature DB >> 508161

Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.

H Lassmann, H M Wisniewski.   

Abstract

Clinical and neuropathological observations in chronic, relapsing experimental allergic encephalomyelitis (EAE) are reported and compared with data available for multiple sclerosis (MS). Clinical, relapsing EAE was found in 95 of 119 of the strain 13 and 22 of 57 of the Hartley guinea pigs immunized. Examination of the brains and spinal cords of the guinea pigs showed a high incidence of macroscopically visible, demyelinated plaques. The topographic distribution of lesions resembled a pattern similar to that described in MS. Microscopic features of the lesions consisted of perivenous inflammation, primary demyelination, oligodendrocyte loss, and reactive gliosis. It is concluded that, with the exception of minor differences, the clinical and pathological alterations in chronic, relapsing EAE closely resemble those found in MS.

Entities:  

Mesh:

Year:  1979        PMID: 508161     DOI: 10.1001/archneur.1979.00500440060011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  29 in total

1.  S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats.

Authors:  Anandakumar Shunmugavel; Mushfiquddin Khan; Marcus M Martin; Anne G Copay; Brian R Subach; Thomas C Schuler; Inderjit Singh
Journal:  Neurosci Med       Date:  2012-09-25

2.  MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Authors:  Stefanie Kuerten; Dilyana A Kostova-Bales; Lukas P Frenzel; Justine T Tigno; Magdalena Tary-Lehmann; Doychin N Angelov; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2007-07-25       Impact factor: 3.478

Review 3.  The fate of T cells in the brain: veni, vidi, vici and veni, mori.

Authors:  P V Lehmann
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

4.  Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques.

Authors:  D Gambi; T Fulgente; D Melchionda; M Onofrj
Journal:  Ital J Neurol Sci       Date:  1996-02

5.  Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).

Authors:  H D Webster; H Shii; H Lassmann
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

6.  Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2.

Authors:  Zhe Ji; Zhiqin Fan; Ying Zhang; Ronghuan Yu; Haihua Yang; Chenghua Zhou; Jia Luo; Zun-Ji Ke
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

7.  Basic sciences and clinical neurology: a firsthand experience.

Authors:  G Macchi
Journal:  Ital J Neurol Sci       Date:  1988-08

8.  SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Zhe Ji; Zun-Ji Ke; Jian-Guo Geng
Journal:  Immunol Cell Biol       Date:  2011-06-07       Impact factor: 5.126

9.  A new model for multiple sclerosis: chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane.

Authors:  N Tsukada; C S Koh; N Yanagisawa; A Okano; W M Behan; P O Behan
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin.

Authors:  H Lassmann; K Kitz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.